Precise AI-Controlled Radiofrequency Versus Biofeedback-Electrical Stimulation in Women With Myofascial Pelvic Pain Syndrome: A Comparative Study

Precise AI-Controlled Radiofrequency Versus Biofeedback-Electrical Stimulation in Women With Myofascial Pelvic Pain Syndrome: A Comparative Study

Study Summary: Comparison of Two Treatments for Female Myofascial Pelvic Pain Syndrome The goal of this study is to compare two treatment methods-precise AI-controlled radiofrequency therapy versus biofeedback combined with electrical stimulation-for their clinical effectiveness in female Myofascial Pelvic Pain Syndrome . The study also evaluates the differences between the two therapies in relieving pain, improving sexual function, restoring pelvic floor muscle strength, and reducing anxiety.

The main questions it aims to answer are:

Does precise AI-controlled radiofrequency therapy outperform biofeedback combined with electrical stimulation in relieving pain and reducing pelvic floor hypertonicity?

Do the two therapies differ in their effects on improving patients' sexual function and anxiety levels?

Which treatment regimen is more effective in restoring pelvic floor muscle strength and stability?

Researchers randomly assigned 70 female MPPS patients into two groups (35 patients each). One group received precise AI-controlled radiofrequency therapy (5 sessions, completed over approximately 12 weeks), while the other group received biofeedback combined with electrical stimulation (10 sessions, completed over approximately 3 weeks). Treatment outcomes were compared using Glazer pelvic floor surface electromyography (sEMG) assessment, Visual Analogue Scale (VAS) pain scores, the Female Sexual Function Index (FSFI), and anxiety scores.

Participants will:

Receive pelvic floor physical therapy for 3 to 12 weeks, depending on their group assignment

Undergo Glazer pelvic floor surface electromyography (sEMG) assessment before and after treatment to measure resting tension and muscle strength of the pelvic floor muscles

Complete pain (VAS), sexual function (FSFI), and anxiety (HADS-A) questionnaires before and after treatment

Be guided throughout the treatment by professional pelvic floor rehabilitation therapists, who will adjust parameters (e.g., current intensity, radiofrequency temperature) based on the patient's subjective comfort level during treatment

Inclusion Criteria:

• Female patients with a confirmed diagnosis of MPPS
• Have signed the informed consent form
• Aged over 18 years old and sexually active

Exclusion Criteria:

• Concurrent vaginitis;
• Pregnancy, pre-pregnancy, or within 6 months postpartum
• Abnormal vaginal bleeding
• Severe systemic conditions
• Internal metallic implants
• Skin lesions in the treatment region
• Organic pelvic pathologies
• Systemic or neuropathic pain syndromes
• Concurrent use of pharmacological therapy
• intolerance to the current treatment protocol.